// App-Quantinova.ai

AB0895 : SERUM BIOMARKERS TO PREDICT CLINICAL RESPONSE IN PROOF-OF-CONCEPT TRIALS IN SPONDYLOARTHRITIS

Researchers

Presenter

  • M. Turina

Principal Investigators

  • N. Yeremenko

  • J. Paramarta

  • B. Vandooren

  • P.P. Tak

  • L. De Rijcke

  • D. Baeten

Medical Centers

  • Clinical Pharmacology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Spondyloarthritis

Biomarkers

  • Pentraxin-3

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Vascular endothelial growth factor A

Drug/Treatment

  • ILS-969

  • Infliximab

  • PTX-3

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved